News Medical on MSN
Study reveals previously unknown role for viral protein integrase in HIV's life cycle
The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it.
Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously unknown mechanism by which HIV-1 selects its integration targets in the human ...
Researchers revealed that HIV integrase forms structural filaments within the viral capsid, enabling viral infectivity. The ...
A recent study confirms lenacapavir's effectiveness against HIV and highlights the capsid as a promising drug target despite resistance.
NAIROBI, Feb. 18 (Xinhua) -- Kenya's Ministry of Health has received an initial consignment of 21,000 starter doses of Lenacapavir, a twice-yearly injectable drug for HIV prevention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results